Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)

INR 688.55

(0.19%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 2.17 Billion 1.94 Billion 1.64 Billion 1.64 Billion 1.48 Billion 1.35 Billion
Total Current Assets 1.99 Billion 1.64 Billion 1.09 Billion 1.18 Billion 963.06 Million 975.58 Million
Cash And Short Term Investments 1.47 Billion 1.14 Billion 474.01 Million 641.74 Million 395.35 Million 385.34 Million
Cash and Cash Equivalents 1.47 Billion 110.53 Million 225.26 Million 589.43 Million 395.35 Million 385.34 Million
Short Term Investments 1.35 Billion 1.03 Billion 248.75 Million 52.31 Million - 309.54 Million
Net Receivables 109.51 Million 221.08 Million 165.89 Million 142.18 Million 224.54 Million 212.71 Million
Inventory 149.97 Million 206.76 Million 297.42 Million 297.24 Million 293.25 Million 326.92 Million
Other Current Assets 253.72 Million 80.7 Million -81 Thousand 120.64 Million 1.64 Million 9.4 Million
Total Non-Current Assets 178.24 Million 303.87 Million 551.44 Million 461.86 Million 523.87 Million 382.25 Million
Net PPE 93.02 Million 242.78 Million 225.73 Million 233.47 Million 239.63 Million 235.05 Million
Good Will And Intangible Assets -22.5 Million 6.51 Million 300 Thousand 300 Thousand 23.75 Million 20.92 Million
Good Will - - 300 Thousand 300 Thousand 300 Thousand 300 Thousand
Intangible Assets - - 23.45 Million 23.45 Million 23.45 Million 20.62 Million
Long-Term Investments 51.7 Million 33.84 Million 290.55 Million 120.58 Million 113.86 Million 5000.00
Tax Assets 22.5 Million 410 Thousand 8.64 Million 21.1 Million 275 Thousand 661 Thousand
Other Non Current Assets 33.52 Million 20.32 Million 26.22 Million 86.4 Million 146.34 Million 125.6 Million
Other Assets - - - - - -
Total Liabilities 296.76 Million 360.56 Million 314.66 Million 399.38 Million 376.59 Million 313.11 Million
Total Current Liabilities 191.28 Million 275.71 Million 269.72 Million 375.84 Million 345.68 Million 281.91 Million
Account Payables 75.96 Million 163.63 Million 185.5 Million 206.85 Million 117.09 Million 118.6 Million
Tax Payables - 190 Thousand 2.33 Million 4.5 Million 9.07 Million 11.25 Million
Short Term Debt 13.84 Million 7.54 Million - 67.88 Million 64.03 Million 37.85 Million
Deferred Revenue 74.66 Million 6.12 Million - 56.79 Million 151.68 Million 80.72 Million
Other Current Liabilities 26.82 Million 98.42 Million 84.22 Million 44.32 Million 12.86 Million 44.73 Million
Total Non Current Liabilities 105.48 Million 84.85 Million 44.94 Million 23.54 Million 30.91 Million 31.19 Million
Long-Term Debt 75.57 Million 52.47 Million - - - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 9.18 Million 10.75 Million 12.56 Million 180 Thousand - -
Other Liabilities - - - - - -
Total Equity 1.87 Billion 1.58 Billion 1.32 Billion 1.24 Billion 1.11 Billion 1.04 Billion
Stock Holders Equity 1.87 Billion 1.58 Billion 1.32 Billion 1.24 Billion 1.11 Billion 1.04 Billion
Common Stock 132.19 Million 130.99 Million 130.99 Million 130.99 Million 130.99 Million 130.99 Million
Retained Earnings 1.04 Billion 945.37 Million 693.71 Million 585.88 Million 476.93 Million 411.32 Million
Accumulated other comprehensive income 1.74 Billion 136.99 Million 136.99 Million 136.99 Million 136.99 Million 136.99 Million
Common Stock Equity 1.87 Billion 1.58 Billion 1.32 Billion 1.24 Billion 1.11 Billion 1.04 Billion
Capital Lease Obligation 75.57 Million 60.01 Million 52.47 Million - - -
Total Investments 51.7 Million 33.84 Million 290.55 Million 214 Million 113.86 Million 5000.00
Total Debt 89.41 Million 60.01 Million - 67.88 Million 64.03 Million 37.85 Million
Net Debt -1.38 Billion -50.52 Million -225.26 Million -521.55 Million -331.31 Million -347.49 Million

Balance Sheet Charts